Donor vaccination: Is it necessary to prevent hepatitis B virus recurrence after living donor liver transplantation?

被引:1
|
作者
Jiang, Li [1 ]
Liao, Anque [2 ]
Yan, Lunan [1 ]
Yang, Jiayin [1 ]
机构
[1] Sichuan Univ, Liver Transplantat Ctr, Dept Liver Surg, West China Hosp, Chengdu 610064, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Chengdu 610064, Sichuan, Peoples R China
关键词
IMMUNOGLOBULIN; LAMIVUDINE; PROPHYLAXIS;
D O I
10.1002/lt.23796
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:397 / 398
页数:2
相关论文
共 50 条
  • [31] Significance of Hepatitis B Recurrence in Liver Transplantation Recipients
    Chou, Hong-Shiue
    Cheng, Chih-Hsien
    Hung, Hao-Chien
    Lee, Jin-Chiao
    Wang, Yu-Chao
    Wu, Tsung-Han
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chan, Kun-Ming
    Lee, Wei-Chen
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [32] Prevention of hepatitis B recurrence after liver transplantation
    Seehofer, D
    Berg, T
    TRANSPLANTATION, 2005, 80 (01) : S120 - S124
  • [33] Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria
    Jiang, Li
    Yan, Lu-Nan
    Wen, Tian-Fu
    Li, Bo
    Yang, Jia-Yin
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2013, 12 (05) : 494 - 499
  • [35] Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation
    Jiang, Li
    Jiang, Li-Sheng
    Cheng, Nan-Sheng
    Yan, Lu-Nan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (20) : 2489 - 2499
  • [36] Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation
    Lens, Sabela
    Garcia-Eliz, Maria
    Fernandez, Inmaculada
    Castells, Lluis
    Bonacci, Martin
    Mas, Antoni
    Crespo, Gonzalo
    Buti, Maria
    Prieto, Martin
    Forns, Xavier
    LIVER INTERNATIONAL, 2018, 38 (11) : 1940 - 1950
  • [37] Adult-to-adult right-lobe living donor liver transplantation in high model for end-stage liver disease score recipients with hepatitis B virus-related benign liver diseases
    Jiang, Li
    Yan, Lunan
    Tan, Yongqiong
    Li, Bo
    Wen, Tianfu
    Yang, Jiayin
    Zhao, Jichun
    SURGERY TODAY, 2013, 43 (09) : 1039 - 1048
  • [38] Correlation Between Risk of Hepatitis B Virus Recurrence and Tissue Expression of Covalently Closed Circular DNA in Living Donor Liver Transplant Recipients Treated With High-dose Hepatitis B Immunoglobulin
    Song, G. -W.
    Ahn, C. -S.
    Lee, S. -G.
    Hwang, S.
    Kim, K. -H.
    Moon, D. -B.
    Ha, T. -Y.
    Jung, D. -H.
    Park, G. -C.
    Kang, S. -H.
    Jung, B. -H.
    Kim, N.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (10) : 3548 - 3553
  • [39] The role of hepatitis B core-related antigen in predicting hepatitis B virus recurrence after liver transplantation
    Yu, Jiong
    Ye, Yali
    Liu, Jingqi
    Xu, Yanping
    Lou, Bin
    Zhu, Jiaqi
    Sheng, Xinyu
    Feng, Xudong
    Pan, Qiaoling
    Yang, Jinfeng
    Cao, Hongcui
    Li, Lanjuan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (09) : 1025 - 1036
  • [40] Changes in Surgical Site Infections after Living Donor Liver Transplantation
    Yamamoto, Masaki
    Takakura, Shunji
    Iinuma, Yoshitsugu
    Hotta, Go
    Matsumura, Yasufumi
    Matsushima, Aki
    Nagao, Miki
    Ogawa, Kohei
    Fujimoto, Yasuhiro
    Mori, Akira
    Ogura, Yasuhiro
    Kaido, Toshimi
    Uemoto, Shinji
    Ichiyama, Satoshi
    PLOS ONE, 2015, 10 (08):